Amgen, the US biotechnology company, is buying Abgenix for $2.2bn (€1.8bn) in the largest M&A deal in the US biotech sector. Morgan Stanley is advising Amgen and Goldman Sachs is adviser to Abgenix.
Sullivan & Cromwell is legal counsel to Amgen and Dewey Ballantine is legal adviser for Abgenix.